Loading insider details...
Latest Form 4 (Jun 23, 2026): Sale of 39,120 MLTX shares, $862.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 39,120 | $862.2K |
| Jun 18, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 15,082 | $296.8K |
| May 13, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 13,653 | $273.3K |
| Apr 16, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 2,426 | $47.5K |
| Apr 10, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 85,870 | $1.63M |
| Jan 9, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 354,296 | n/a |
| Dec 22, 2025 | MoonLake Immunotherapeutics (MLTX) | Conversion | 294,473 | n/a |
| Oct 9, 2025 | MoonLake Immunotherapeutics (MLTX) | Purchase | 10,870 | $98.8K |
| Mar 4, 2025 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 95,763 | n/a |
| Dec 21, 2023 | MoonLake Immunotherapeutics (MLTX) | Sale | 94,736 | $5.61M |